Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.
Int J Mol Sci
; 19(3)2018 Mar 03.
Article
in En
| MEDLINE
| ID: mdl-29510517
Full text:
1
Database:
MEDLINE
Main subject:
Benzamides
/
NF-kappa B
/
Cyclohexanones
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Int J Mol Sci
Year:
2018
Type:
Article
Affiliation country:
Japan